Search


USFDA Announcement: Facility Fee Rates for OTC Monograph Drug User Fee Program (OMUFA) for FY 2025
The U.S. Food and Drug Administration (FDA)Â has announced the release of " Over-the-Counter Monograph Drug User Fee Program-Facility Fee...
Sharan Murugan
3 days ago2 min read
33 views
1 comment


EMA User Guide: For Micro, Small, and Medium-Sized Enterprises (SMEs)
The European Medicines Agency (EMA)Â has released a " User Guide for Micro, Small, and Medium-Sized Enterprises (SMEs) "Â to help...
Sharan Murugan
6 days ago2 min read
9 views
0 comments


SAHPRA Regulatory Information Management System (RIMS): Cancellation of Health Product Registrations for Non-eCTDs
The South African Health Products Regulatory Authority (SAHPRA)Â has issued a Communication to the industry " Regulatory Information...
Sharan Murugan
Mar 162 min read
17 views
0 comments


EMA IRIS Guide for Applicants: A Comprehensive Overview
The European Medicines Agency (EMA)Â has released the updated " IRIS Guide for Applicants , " which provides detailed instructions on how...
Sharan Murugan
Mar 163 min read
15 views
0 comments


MHRA Guidance: Good Clinical Practice (GCP) for Clinical Trials
The Medicines and Healthcare Products Regulatory Agency (MHRA)Â has released updated guidance on " Good Clinical Practice (GCP)Â for...
Sharan Murugan
Mar 153 min read
9 views
0 comments


UK MHRA: Guidance on Regulation and Licensing of Advanced Therapy Medicinal Products (ATMPs) in the UK
To legally sell or supply an Advanced Therapy Medicinal Product (ATMP) in the United Kingdom, you must obtain a marketing authorisation...
Sharan Murugan
Mar 92 min read
18 views
0 comments


Swissmedic Guidance: Renewal, Discontinuation, and Status Change of Medicinal Product Authorizations
The Swiss Agency for Therapeutic Products (Swissmedic)Â has released an updated guidance, " Renewal, Discontinuation, and Status Change of...
Sharan Murugan
Mar 32 min read
16 views
0 comments


Swissmedic Guidance: Submission of PSUR/PBRER Submission for Human Medicinal Products
The Swiss Agency for Therapeutic Products (Swissmedic)Â has released an updated guidance" Submission of Periodic Safety Update Reports...
Sharan Murugan
Mar 32 min read
22 views
0 comments


India CDSCO: Adding Trial Sites and Changing Principal Investigators
Clinical trials are a cornerstone of medical advancement, requiring meticulous planning and adherence to regulatory guidelines. In India,...
Sharan Murugan
Mar 33 min read
8 views
0 comments

EMA Procedural Advice: Appointment of CHMP, CAT, and PRAC Rapporteurs and Co-Rapporteurs
The European Medicines Agency (EMA)Â has released an updated procedural guidance document on the " Appointment of CHMP, CAT, and PRAC...
Sharan Murugan
Mar 12 min read
17 views
0 comments

MHRA Guidance: Format and Content of Applications for Agreement or Modification of a Paediatric Investigation Plan
The Medicines and Healthcare products Regulatory Agency (MHRA)Â has established comprehensive guidelines detailing the " Format and...
Sharan Murugan
Feb 282 min read
20 views
0 comments


EMA Addendum: Clinical Development of Vaccines in Immunocompromised Individuals
The European Medicines Agency (EMA) has released an addendum to its Guideline on the " Clinical Development of Vaccines to address the...
Sharan Murugan
Feb 272 min read
10 views
0 comments


EMA Concept Paper: Guideline on Mechanistic Models in Model-Informed Drug Development (MIDD)
The European Medicines Agency (EMA) has released a concept paper  proposing the development of a guideline for the assessment and...
Sharan Murugan
Feb 222 min read
24 views
0 comments


FDA Philippines: Draft Guidelines for Registration of Chemical and Biological Pharmaceutical Products
The Food and Drug Administration (FDA) of the Philippines has recently published draft guidelines to streamline the registration process...
Sharan Murugan
Feb 222 min read
18 views
0 comments


SAHPRA South Africa: Renewal of the Certificate of Registration - Fee Schedule and Explanatory Notes
The South African Health Products Regulatory Authority (SAHPRA)Â has updated its " Fee Schedule and Explanatory Notes " Â to renew human...
Sharan Murugan
Feb 192 min read
12 views
0 comments

South Africa's SAHPRA: Renewal Process for Human -A Comprehensive Guide
The South African Health Products Regulatory Authority (SAHPRA) is responsible for monitoring, evaluating, and regulating the renewal of...
Sharan Murugan
Feb 122 min read
30 views
0 comments


UK MHRA Guidance: Managing Clinical Trial Authorisations & Safety Reporting (Updated 2025)
The UK Medicines and Healthcare products Regulatory Agency (MHRA)Â has updated its guidance on " Clinical trials for medicines: manage...
Sharan Murugan
Feb 92 min read
33 views
0 comments

UK MHRA Guidance: Exceptions and Modifications to the EU Good Pharmacovigilance Practices (GVP) for UK MAHs
The Medicines and Healthcare Products Regulatory Agency (MHRA) has released updated guidance on pharmacovigilance requirements that...
Sharan Murugan
Feb 82 min read
49 views
0 comments


UK MHRA Draft Guideline: Individualised mRNA Cancer Immunotherapies
The Medicines and Healthcare products Regulatory Agency (MHRA) has recently initiated a public consultation on draft guidance for "...
Sharan Murugan
Feb 52 min read
12 views
0 comments


USFDA Guidance: Institutional Review Board (IRB) Written Procedures
Institutional Review Boards (IRBs) play a crucial role in safeguarding the rights and welfare of human research subjects. To enhance...
Sharan Murugan
Feb 52 min read
7 views
0 comments